In Yet Another Sign That Psychedelics Are Making Their Way Into the Mainstream, Compass Pathways, a UK-Based Psychedelics Startup Focused on Producing Psilocybin, Has Filed for its Initial Public Offering... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of August 24th – 30th, 2020.... read more →
Psychedelics Companies That Own Clinics May Hold the Answer to One of the Top Investor Questions: "How Will Individual Firms Generate Meaningful Revenue?" As We Know, the Business of Biotech... read more →
While there have been glimmers of an upturn recently in the cannabis industry, the drama of the business of selling a federally illegal cash crop continues. And there is little... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelics industry news stories for the week of April 27th – May 3rd,... read more →
Compass Pathways Received an $80 Million Boost from Investors to Expand its Exploration of Psilocybin as a Therapy for Treatment-Resistant Depression The Psychedelics Mental Health Company Plans to Run Several... read more →
ATAI Life Sciences Will Use the Proceeds from its $24 Million Convertible Note Financing to Explore the Effects of Psychedelic Medicine on Mental Health A New Group of Renowned Investors... read more →
